• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三大洲 11 个国家的糖尿病视网膜病变患病率及相关危险因素的差异:156090 例 1 型糖尿病儿童和青少年的横断面研究。

Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross-sectional study of 156,090 children and adolescents with type 1 diabetes.

机构信息

Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Ljubljana, Slovenia.

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Pediatr Diabetes. 2022 Dec;23(8):1656-1664. doi: 10.1111/pedi.13416. Epub 2022 Sep 22.

DOI:10.1111/pedi.13416
PMID:36097824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9771999/
Abstract

OBJECTIVE

To examine the prevalence, time trends, and risk factors of diabetic retinopathy (DR) among youth with type 1 diabetes (T1D) from 11 countries (Australia, Austria, Denmark, England, Germany, Italy, Luxemburg, Netherlands, Slovenia, United States, and Wales).

SUBJECTS AND METHODS

Data on individuals aged 10-21 years with T1D for >1 year during the period 2000-2020 were analyzed. We used a cross-sectional design using the most recent year of visit to investigate the time trend. For datasets with longitudinal data, we aggregated the variables per participant and observational year, using data of the most recent year to take the longest observation period into account. DR screening was performed through quality assured national screening programs. Multiple logistic regression models adjusted for the year of the eye examination, age, gender, minority status, and duration of T1D were used to evaluate clinical characteristics and the risk of DR.

RESULTS

Data from 156,090 individuals (47.1% female, median age 15.7 years, median duration of diabetes 5.2 years) were included. Overall, the unadjusted prevalence of any DR was 5.8%, varying from 0.0% (0/276) to 16.2% between countries. The probability of DR increased with longer disease duration (aOR  = 1.04, 95% CI: 1.03-1.04, p < 0.0001), and decreased over time (aOR  = 0.99, 95% CI: 0.98-1.00, p = 0.0093). Evaluating possible modifiable risk factors in the exploratory analysis, the probability of DR increased with higher HbA1c (aOR  = 1.03, 95% CI: 1.03-1.03, p < 0.0001) and was higher among individuals with hypertension (aOR = 1.24, 95% CI: 1.11-1.38, p < 0.0001) and smokers (aOR = 1.30, 95% CI: 1.17-1.44, p < 0.0001).

CONCLUSIONS

The prevalence of DR in this large cohort of youth with T1D varied among countries, increased with diabetes duration, decreased over time, and was associated with higher HbA1c, hypertension, and smoking.

摘要

目的

检查 11 个国家(澳大利亚、奥地利、丹麦、英格兰、德国、意大利、卢森堡、荷兰、斯洛文尼亚、美国和威尔士)的 1 型糖尿病(T1D)青年中糖尿病视网膜病变(DR)的患病率、时间趋势和危险因素。

方法

分析了 2000-2020 年期间患有 T1D 且患病时间超过 1 年的 10-21 岁个体的数据。我们使用横断面设计,根据最近的就诊年份调查时间趋势。对于具有纵向数据的数据集,我们根据每个参与者和观察年份汇总变量,使用最新年份的数据考虑最长的观察期。DR 筛查通过质量保证的国家筛查计划进行。使用调整了眼部检查年份、年龄、性别、少数族裔身份和 T1D 持续时间的多因素逻辑回归模型来评估临床特征和 DR 风险。

结果

共纳入 156090 名个体(47.1%为女性,中位年龄 15.7 岁,中位糖尿病病程 5.2 年)。总体而言,未经调整的任何 DR 患病率为 5.8%,各国之间差异从 0.0%(0/276)到 16.2%不等。DR 的发生概率随疾病持续时间的延长而增加(优势比 aOR=1.04,95%置信区间:1.03-1.04,p<0.0001),并且随时间呈下降趋势(aOR=0.99,95%置信区间:0.98-1.00,p=0.0093)。在探索性分析中评估可能的可改变危险因素时,DR 的发生概率随 HbA1c 升高而增加(aOR=1.03,95%置信区间:1.03-1.03,p<0.0001),并且在高血压(aOR=1.24,95%置信区间:1.11-1.38,p<0.0001)和吸烟者(aOR=1.30,95%置信区间:1.17-1.44,p<0.0001)中更高。

结论

在该大型 T1D 青年队列中,DR 的患病率在各国之间存在差异,随糖尿病病程的延长而增加,随时间的推移而下降,并且与更高的 HbA1c、高血压和吸烟有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c1/10087218/a0b42756718a/PEDI-23-1656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c1/10087218/a0b42756718a/PEDI-23-1656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c1/10087218/a0b42756718a/PEDI-23-1656-g001.jpg

相似文献

1
Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross-sectional study of 156,090 children and adolescents with type 1 diabetes.三大洲 11 个国家的糖尿病视网膜病变患病率及相关危险因素的差异:156090 例 1 型糖尿病儿童和青少年的横断面研究。
Pediatr Diabetes. 2022 Dec;23(8):1656-1664. doi: 10.1111/pedi.13416. Epub 2022 Sep 22.
2
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
3
Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes.1464 例 1 型糖尿病成年患者糖尿病视网膜病变的患病率、严重程度分期和危险因素。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3613-3623. doi: 10.1007/s00417-021-05298-7. Epub 2021 Jul 15.
4
Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.城市三级眼科中心儿童和青少年糖尿病视网膜病变的患病率。
Pediatr Diabetes. 2020 Aug;21(5):856-862. doi: 10.1111/pedi.13037. Epub 2020 May 31.
5
Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study.芬兰 1 型糖尿病儿童和青少年视网膜病变的患病率:一项基于人群的横断面回顾性研究。
Arch Dis Child. 2011 Oct;96(10):963-8. doi: 10.1136/adc.2011.210807. Epub 2011 Jun 29.
6
Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark.丹麦菲英岛17152例患者糖尿病视网膜病变的患病率及危险因素
Acta Ophthalmol. 2017 Dec;95(8):778-786. doi: 10.1111/aos.13449. Epub 2017 Apr 26.
7
Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.美国1型或2型糖尿病青少年发生糖尿病视网膜病变的发病率及危险因素
Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30.
8
Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes.与年轻糖尿病患者糖尿病视网膜病变相关的临床和人口统计学因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2126126. doi: 10.1001/jamanetworkopen.2021.26126.
9
Diabetic Retinopathy Screening in Patients with Diabetes Using a Handheld Fundus Camera: The Experience from the South-Eastern Region in Hungary.匈牙利东南部地区使用手持式眼底相机对糖尿病患者进行糖尿病视网膜病变筛查的经验。
J Diabetes Res. 2021 Feb 5;2021:6646645. doi: 10.1155/2021/6646645. eCollection 2021.
10
Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes.探究八个高收入国家内及国家间的血糖控制差异:64666 例 1 型糖尿病儿童和青少年的横断面分析。
Diabetes Care. 2018 Jun;41(6):1180-1187. doi: 10.2337/dc17-2271. Epub 2018 Apr 12.

引用本文的文献

1
Ocular findings in children, adolescents and young adults with type 1 diabetes mellitus in ghana: a cross-sectional study.加纳1型糖尿病儿童、青少年及青年的眼部检查结果:一项横断面研究
BMC Ophthalmol. 2025 Jul 1;25(1):366. doi: 10.1186/s12886-025-04187-5.
2
Prevalence of vision impairment among patients with diabetes mellitus in sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区糖尿病患者视力损害的患病率:一项系统评价和荟萃分析。
PLoS One. 2025 Jun 24;20(6):e0326176. doi: 10.1371/journal.pone.0326176. eCollection 2025.
3
Diagnostic Biomarkers of Microvascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus-An Updated Review.

本文引用的文献

1
14. Children and Adolescents: Standards of Medical Care in Diabetes-2022.14. 儿童和青少年:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S208-S231. doi: 10.2337/dc22-S014.
2
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.10. 心血管疾病和风险管理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S144-S174. doi: 10.2337/dc22-S010.
3
Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period.50 年期间基于人群的青少年糖尿病患者眼部并发症的研究。
1型糖尿病儿童和青少年微血管并发症的诊断生物标志物——最新综述
Pediatr Rep. 2024 Sep 5;16(3):763-778. doi: 10.3390/pediatric16030064.
4
Prevalence and Predictors of Diabetic Retinopathy, Its Progression and Regression in Indian Children and Youth With Type-1 Diabetes.印度1型糖尿病儿童及青少年糖尿病视网膜病变的患病率、预测因素、病情进展及转归
Clin Med Insights Endocrinol Diabetes. 2024 Sep 2;17:11795514241275921. doi: 10.1177/11795514241275921. eCollection 2024.
5
Telemedicine in Improving Glycemic Control Among Children and Adolescents With Type 1 Diabetes Mellitus: Systematic Review and Meta-Analysis.远程医疗在改善 1 型糖尿病患儿血糖控制中的应用:系统评价和荟萃分析。
J Med Internet Res. 2024 Jul 9;26:e51538. doi: 10.2196/51538.
6
A GDPR-Compliant Dynamic Consent Mobile Application for the Australasian Type-1 Diabetes Data Network.一款符合通用数据保护条例(GDPR)的动态同意移动应用程序,用于澳大拉西亚1型糖尿病数据网络。
Healthcare (Basel). 2023 Feb 8;11(4):496. doi: 10.3390/healthcare11040496.
JAMA Ophthalmol. 2022 Jan 1;140(1):51-57. doi: 10.1001/jamaophthalmol.2021.5052.
4
Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes.性别相关差异在 1 型糖尿病患儿和青少年心血管疾病风险特征中的表现。
Int J Mol Sci. 2021 Sep 22;22(19):10192. doi: 10.3390/ijms221910192.
5
Sight-threatening retinopathy in nine adolescents with early onset type 1 diabetes.九名青少年起病 1 型糖尿病患者的视力威胁性视网膜病变。
Pediatr Diabetes. 2021 Dec;22(8):1129-1134. doi: 10.1111/pedi.13265. Epub 2021 Sep 23.
6
Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths.青少年糖尿病视网膜病变筛查中的种族/民族差异和障碍。
JAMA Ophthalmol. 2021 Jul 1;139(7):791-795. doi: 10.1001/jamaophthalmol.2021.1551.
7
Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET.血糖控制结果与 1 型糖尿病患儿和青少年使用胰岛素泵和血糖传感器相关。来自国际儿科登记研究 SWEET 的数据。
Diabetes Care. 2021 May;44(5):1176-1184. doi: 10.2337/dc20-1674. Epub 2021 Mar 2.
8
The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth.SEE 研究:在青少年糖尿病视网膜病变诊断中实施自主人工智能的安全性、有效性和公平性。
Diabetes Care. 2021 Mar;44(3):781-787. doi: 10.2337/dc20-1671. Epub 2021 Jan 21.
9
Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy.糖尿病患者及新诊断糖尿病视网膜病变患者的失明风险。
Diabetes Care. 2021 Mar;44(3):748-756. doi: 10.2337/dc20-0413. Epub 2021 Jan 20.
10
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study.LDL 胆固醇水平作为 1 型糖尿病儿童和成人视网膜病变和肾病的风险因素:一项全国性队列研究。
J Intern Med. 2021 Jun;289(6):873-886. doi: 10.1111/joim.13212. Epub 2020 Dec 27.